BlackRock Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$343K Sell
9,468
-23,813
-72% -$904K ﹤0.01% 2435
2016
Q3
$1.42M Buy
33,281
+903
+3% +$40.3K ﹤0.01% 1638
2016
Q2
$1.37M Buy
32,378
+1,160
+4% +$50.4K ﹤0.01% 1625
2016
Q1
$1.3M Buy
31,218
+331
+1% +$13K ﹤0.01% 1626
2015
Q4
$1.21M Sell
30,887
-4,030
-12% -$151K ﹤0.01% 1625
2015
Q3
$1.18M Sell
34,917
-1,143
-3% -$40.7K ﹤0.01% 1588
2015
Q2
$1.19M Buy
36,060
+328
+0.9% +$11.3K ﹤0.01% 1546
2015
Q1
$1.28M Buy
35,732
+1,657
+5% +$52.1K ﹤0.01% 1419
2014
Q4
$1.02M Buy
34,075
+23,359
+218% +$685K ﹤0.01% 1480
2014
Q3
$332K Sell
10,716
-769
-7% -$25.5K ﹤0.01% 2280
2014
Q2
$416K Sell
11,485
-1,617
-12% -$52.3K ﹤0.01% 2144
2014
Q1
$395K Sell
13,102
-289
-2% -$6.66K ﹤0.01% 2221
2013
Q4
$306K Buy
13,391
+1,281
+11% +$26.8K ﹤0.01% 2379
2013
Q3
$252K Sell
12,110
-81,931
-87% -$1.99M ﹤0.01% 2391
2013
Q2
$2.53M Buy
+94,041
New +$2.82M ﹤0.01% 1105

Other funds holding OFIX

BlackRock Advisors's OFIX Position: Q4 2016 in Review

BlackRock Advisors reduced its Orthofix Medical (OFIX) stake by 72% in Q4 2016, selling an estimated $904K and leaving 9,468 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

BlackRock Advisors first reported a position in OFIX in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.53M in Q2 2013. 136 funds tracked by Wall St. Rank hold OFIX as of Q4 2016.

  • BlackRock Advisors held 9,468 shares of Orthofix Medical worth $343K as of Q4 2016.
  • BlackRock Advisors sold 23,813 Orthofix Medical shares in Q4 2016, an estimated $904K.
  • Orthofix Medical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2435 holding.
  • BlackRock Advisors first reported a position in Orthofix Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Orthofix Medical position peaked at $2.53M in Q2 2013.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.